Adlai Nortye Ltd. (ANL)
Nasdaq: ANL · Pharmaceutical Preparations · North Brunswick, NJ · filing with the SEC since 2022
Who owns Adlai Nortye Ltd.
As filed with the SECHolders of 5% or more
2
ANL Talent Limited holds 7.75% of Ordinary shares, par value US$0.0001 per share, as its SCHEDULE 13G filed Jan 16, 2026 says.
Directors and officers
8
report now, of 8 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
ANL Talent Limited
SCHEDULE 13G · filed Jan 16, 2026 · Ordinary shares, par value US$0.0001 per share
Cormorant Asset Management, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · American Depositary Shares, each representing three Class A Ordinary Shares · 5.19% in May 15, 2026
Boary Investment Co. Ltd.
SCHEDULE 13G · filed Apr 29, 2025 · Ordinary shares, par value US$0.0001 per share · reported falling below 5%
Venrock Healthcare Capital Partners III, L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Class A Ordinary Shares, par value US$0.0001 per share · reported falling below 5%, from 6.1% in Feb 11, 2026
Jin Yin (Bvi) Limited
SCHEDULE 13G/A · filed May 14, 2026 · Ordinary shares, par value US$0.0001 per share · reported falling below 5%
Unique Mark Ventures Ltd
SCHEDULE 13G/A · filed Feb 9, 2026 · American Depositary Shares, each representing three Class A Ordinary Shares, par value $0.0001 per share · reported falling below 5%, from 6.14% in Jan 20, 2026
What ANL reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Adlai Cayman
An entity · subsidiary · owns, named in the 20-F filed Apr 10, 2026
Adlai Hangzhou
An entity · subsidiary · owns, named in the 20-F filed Apr 10, 2026
Adlai USMember
An entity · subsidiary · owns, named in the 20-F filed Apr 10, 2026
7 subsidiaries in 6 countries, from the list filed with the 20-F filed Apr 30, 2025.
Insider tradesForm 4
7sales
0purchases
0sales on a scheduled plan
3people selling
$400,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 1, 2025 to Oct 1, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 1, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 8 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Ye Xiaofeng | CFO | 2 | $200,000 | 0 | 0 | $0 |
| Ji Ping | director | 4 | $200,000 | 0 | 0 | $0 |
| Lu Yang | CEO | 1 | $0 | 0 | 0 | $0 |